USPTO trademark

NORTHWAY GENE THERAPY

RegisteredUSPTOWord and designClass 5Class 42

"NORTHWAY GENE THERAPY" is a word and design mark owned by UAB "Northway turto valdymas", filed at the USPTO on November 18, 2020. It is registered and covers classes 5 and 42.

View UAB "Northway turto valdymas" portfolioGet this data via the API
Official USPTO record
NORTHWAY GENE THERAPY trademark as filed
As filed with the USPTO
Status
Registered
Since September 27, 2022
Filed
November 18, 2020
Registered
September 27, 2022
Expires
Not recorded
Application no.
79301540
Registration no.
6854457
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
2 classes
Ownership

Who owns NORTHWAY GENE THERAPY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

UAB "Northway turto valdymas"

Lithuania

23 trademarks in the portfolioView company

Representative

John Zaccaria

Notaro Michalos & Zaccaria PC

Goods and services

What the mark covers

The products and services NORTHWAY GENE THERAPY is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19

  • Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the field of development of manufacturing processes for biotechnology products

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Final decision transaction processed by ib
  2. Final disposition notice sent to ib
  3. Final disposition processed
  4. Final disposition notice created, to be sent to ib
  5. Notice of registration confirmation emailed
  6. Registered-principal register
  7. Ttab release case to trademarks
  8. Opposition terminated no. 999999
  9. Opposition dismissed no. 999999
  10. Notification of possible opposition - processed by ib

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About NORTHWAY GENE THERAPY

Who owns the trademark "NORTHWAY GENE THERAPY"?

The USPTO trademark "NORTHWAY GENE THERAPY" (application 79301540) is owned by UAB "Northway turto valdymas".

What is the status of "NORTHWAY GENE THERAPY"?

Its status at the USPTO is: registered.

When was "NORTHWAY GENE THERAPY" registered?

It was registered on September 27, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NORTHWAY GENE THERAPY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2afe-2675-7480-991b-24b84f9b90f3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2afe-2675-7480-991b-24b84f9b90f3",
  "object": "trademark",
  "mark_text": "NORTHWAY GENE THERAPY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "79301540",
  "filing_date": "2020-11-18",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "UAB \"Northway turto valdymas\"",
      "entity_id": "ent_019ebb51-8bf7-7010-be3a-ef849512d7e9"
    }
  ]
}